PerspectivePublished 29 Sep 2022
Divergent immunological characteristics of COVID-19, influenza, and other community-acquired pneumonia are shown by integrated single-cell analysis.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Methodological variability and a dearth of pertinent disease controls continue to cast doubt on the precise immunopathophysiology of Community-Acquired Pneumonia (CAP) brought on by SARS-CoV-2 (COVID-19). It is challenging to differentiate between immunological signs specific to COVID-19 and the typical features of a dysregulated host response to pneumonia since single-cell examinations in the larger population of patients with CAP are not routinely performed. Expanding our understanding of the peripheral immune response in various pneumonia etiologies, we describe shared and diverging transcriptional and phenotypic patterns using this balanced, multi-omics approach, such as in COVID-19, there were higher concentrations of type I interferon-stimulated NK cells, cytotoxic CD8 T EMRA cells in both COVID-19 and influenza, and different monocyte compositions in each group.
Keywords
Subjects
Infectious DiseasesMicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Microbiology and Infectious Diseases
- SubjectInfectious Diseases
- SubjectMicrobiology
- BylineArticles whose byline prints “Robert Klein”
